وَمَنْ أَحْيَاهَا فَكَأَنَّمَا أَحْيَا النَّاسَ جَمِيعًا

Department Publications by Year 93 Faculty

2026

2025

22.

Reviving expired pharmaceuticals using 2-[(butylamino)propan-2-yl]phosphinic acid for corrosion protection of carbon steel in 1.0 M HCl.

Abdel-Hameed R, Ashmawy AM, AlElaimi M, Abourashed NM, Alshammari OAO, Alanazi KD, Deyab MA

Sci Rep (December 2025) , 16(1) : 3338

DOI: doi: 10.1038/s41598-025-33254-6

24.

Efficacy and safety of pharmacological and non-pharmacological interventions for antipsychotic-induced weight gain in individuals with schizophrenia: A systematic review and network meta-analysis of 55 clinical trials.

Mansour MEM, Alsaadany KR, Mustafa MMM, Ahmed MAE, Beddor A, Helal MM, Elgahamy AS, Kassar O, Abdelsalam F, Elmetwalli AE, Sabé M

J Psychopharmacol (December 2025) : 2698811251399544

DOI: doi: 10.1177/02698811251399544

25.

Ferula assafoetida induced colon cancer cells differentiation through JNK/MAPK signalling pathway activation.

Abdelsalam HM, Abdelghany AM, Ahmed WA, Diab AA, Abdellateif MS

World J Exp Med (December 2025) , 15(4) : 110757

DOI: doi: 10.5493/wjem.v15.i4.110757

26.

Future of inflammatory bowel disease treatment: A review of novel treatments beyond guidelines.

Hafez MM, Bahcecioglu IH, Yalniz M, Kouta KA, Tawheed A

World J Methodol (December 2025) , 15(4) : 107643

DOI: doi: 10.5662/wjm.v15.i4.107643

27.

Scarred and complex colorectal polyps: Traditional techniques and emerging alternatives.

Tawheed A, Hafez MM, Ismail A, Madkour A

World J Methodol (December 2025) , 15(4) : 105305

DOI: doi: 10.5662/wjm.v15.i4.105305

28.

Comparative safety and side effects of semaglutide and tirzepatide: Implications for clinical decision-making in obesity management.

Fahim SA, Attia YM, Messiha A, Nabawy AY, Refaat F, El-Maadawy WH

Biomed Pharmacother (December 2025) , 193 : 118731

DOI: doi: 10.1016/j.biopha.2025.118731

29.

Targeting inflammation-driven tumor progression with Zafirlukast via modulation of Jagged-1/Notch-1/Hes-1, Wnt-4/?-catenin, and VEGF signaling pathways in mice.

Saleh A, Mansour DF, Raslan NA, Galal O, Ibrahim S, Hafez MM, Jamil L, Elhusseiny SM, Selim HMRM, Farghly AM, Abdoh HY, Salama LA, Hafez SM, Mahmoud NA, El-Dessouki AM

Naunyn Schmiedebergs Arch Pharmacol (December 2025) , 398(12) : 17609-17632

DOI: doi: 10.1007/s00210-025-04344-z

30.

Severe Late-Onset Neutropenia in a Patient With Multiple Sclerosis Treated With Ocrelizumab.

Mansour MK, Raghunathan R, Mohamed A, Ahmed H, Hassan Y

Cureus (December 2025) , 17(12) : e99574

DOI: doi: 10.7759/cureus.99574